1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Opportunities in Indian API Market

Opportunities in Indian API Market

  • October 2015
  • -
  • RNCOS
  • -
  • 75 pages

Summary

Table of Contents

India, being the third largest API market in the Asia-Pacific region, has been gaining a lot of attention worldwide since the last few years. The accelerated growth of the Indian API market can be attributed to the increased efforts being made by the Indian government to improve the infrastructure of the API industry and provide maximum support to domestic API manufacturers. This is being done, so that India does not have to depend on other countries for the import of APIs. Indian API manufacturers are also trying to strengthen their hold of the regulated markets by various means. A major competitor for India in this field is China, which provides APIs at very low rates. However, all the hard work being put in by the API manufacturers and government will help India to become the top API market not only in Asia-Pacific, but also in the world.

In the report “Opportunities in Indian API Market”, RNCOS analysts have addressed the current scenario of the Indian API market, major drivers of the market, and factors hindering the growth of the market. Apart from this, the segmentation of the market by various parameters, such as type of manufacture, type of drug, type of API and type of therapeutic area, has also been specified. The important mergers and acquisitions in the Indian API market have also been mentioned in the report. Various initiatives taken by the government to promote the Indian API industry have been listed down. Owing to the various government initiatives, such as the declaration of 2015 as the “Year of APIs”, “Make in India” campaign, etc., the Indian API market is likely to show a promising growth in the coming years. The Indian API market is forecasted to grow at a CAGR of 13% from 2014-2020.

The report also mentions the key players in the Indian API Market. For every player, a brief business overview, geographic revenue break up, and segment wise revenue break up has been provided. A strength and weakness analysis of every player has also been presented to assist the investors in developing an understanding of the strategies of major players. A separate section has been provided in the report for the opportunities and recommendations for the development of the Indian API market. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the Indian API market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Idiopathic Pulmonary Fibrosis Pipeline Analysis, 2016 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

Global Idiopathic Pulmonary Fibrosis Pipeline Analysis, 2016 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • $ 6500
  • Industry report
  • February 2017
  • by P&S Market Research

Pipeline Overview Idiopathic pulmonary fibrosis (IPF) is referred to as progressive and chronic interstitial pneumonia without known cause. Pulmonary fibrosis is a disease in which tissue profound in lungs ...

Chronic Kidney Disease (CKD) Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Chronic Kidney Disease (CKD) Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • March 2017
  • by Transparency Market Research

Chronic Kidney Disease (CKD) Drugs Market (Drug Class - ACE Inhibitors, Angiotensin-II Receptor Blockers, Calcium Channel Blockers, Beta Blockers, Erythropoiesis - stimulating Agents (ESAs), and Diuretics; ...

Cholesterol Screening/ Cholesterol Lab Testing Services Market by Type of Customer, Geography & Qualitative Assessment - Forecasts to 2021

Cholesterol Screening/ Cholesterol Lab Testing Services Market by Type of Customer, Geography & Qualitative Assessment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global cholesterol testing services market is expected to reach USD 17.5 billion by 2021 from USD 11.9 billion in 2016, growing at a CAGR of 8% during the forecast period. This market is segmented ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.